Two recent studies observed benefits associated with higher blood omega-3 levels (EPA and DHA) in healthy people, measured by the Omega-3 Index.
Photo © iStockphoto.com/Juxtagirl
Two recent studies published in Prostaglandins, Leukotrienes and Essential Fatty Acids observed benefits associated with higher blood omega-3 levels (EPA and DHA) in healthy people, measured by the Omega-3 Index. The first study1 found that the Omega-3 Index is directly associated with a healthy red blood cell distribution width (RDW), a measure of cellular integrity. Both these measures are related to membrane fluidity and deformability, or the red blood cell’s ability to change shape. Both low Omega-3 Index levels and elevated RDW are risk factors for all-cause mortality. Researchers found an inverse relationship between Omega-3 Index levels and RDW, meaning that the higher the omega-3 levels, the lower the RDW is. Specifically, in healthy adults of both sexes, an Omega-3 Index of greater than 5.6% may help maintain a normal red blood cell structural and functional integrity.
The second study2 investigated the relationship between Omega-3 Index levels and neutrophil-lymphocyte ratio (NLR), which is a biomarker of systemic inflammation that measures innate-adaptive immune system balance. Low Omega-3 Index and elevated NLR are associated with higher risk of chronic disease and mortality. Researchers found that subjects with a higher Omega-3 Index of greater than 6.6% was associated with a lower NLR, while the opposite was true for subjects with an Omega-3 Index of less than 6.6%. This suggests that a higher Omega-3 Index supports a “quiescent, balanced immune system.”
“The NLR paper may be particularly important because most nutrition-immune studies measure circulating levels of inflammatory molecules, i.e., markers of inflammation, making them disease-related findings,” said Michael McBurney, PhD, FCNS-SCN, FASN, a lead author of both papers, and consulting scientist with the Fatty Acid Research Institute, in a press release. He added, “This is a report of an association between nutrient status and immune function/balance based on cells in healthy people.”
“These two reports linking a high Omega-3 Index with low (i.e., healthier) levels of two novel biomarkers — RDW and NLR — help us understand a little better why omega-3 fatty acids are good for us,” said William S. Harris, PhD, FASN, senior author on both studies and President of FARI.
Reference
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.